Flat sale of flu drugs hints at no unusual rise in infections

Industry executives and chemists said the April sales data showed a month-on-month decline of 30-40%. But even though the lockdown is seen to be impacting sales of most drugs, the pattern for medicines for infections and flus is no different.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cXCpKj
via IFTTT